Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...
Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...
Doctors are pulling out new techniques and drugs in an effort to cure devastating brain When you purchase through links on ...